Foto: Colourbox
24-03-2020
With a coordinated and effective effort between the Danish haematological departments, a nationwide study on coronavirus infection among patients with haematological diseases is initiated in a short timespan. The study is now open for haematological patients and it is expected that the entire field of oncology is to be included soon.
The national observational study will follow patients with haematological disorders, who are diagnosed with COVID-19, to determine the effect of patients' comorbidity, age, and immune deficiency. The study will document possible complications of these factors among haematological patient groups, who are particularly vulnerable to infectious diseases.
"We will analyse a large number of data on patients with haematological diseases, including remission, immune system and organ function, life style indicators as well as biochemical markers and compare these with symptoms, treatments and complications of coronavirus. We include all COVID-19 diagnosed haematological patients to ensure the best possible data basis", Henrik Frederiksen, professor and consultant, Haematological Department, Odense University Hospital explains.
All haematological patients who are diagnosed COVID-19 positive with a verified test, and who are scheduled for treatment or follow-up at the haematological departments, can be included in the study. It is estimated that a minimum of 400 patients in Denmark will fulfil these criteria.
"This prompt initiation of data collection on the course of the disease is vital. The national coordination will contribute to a joint effort and knowledge base once we further organise initiatives and treatment for these patients, who are particularly at risk", says Henrik Frederiksen.
A protocol is currently in preparation for a similar study that will include oncology patients in Denmark.